MONOCLONAL ANTIBODIES RAISED AGAINST SENILE PLAQUES AND NEUROFIBRILLARY TANGLES IN ALZHEIMER'S DISEASE

针对阿尔茨海默病中的老年斑块和神经纤维缠结产生的单克隆抗体

基本信息

  • 批准号:
    01480281
  • 负责人:
  • 金额:
    $ 3.52万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1989
  • 资助国家:
    日本
  • 起止时间:
    1989 至 1991
  • 项目状态:
    已结题

项目摘要

Cerebral amyloid deposits of varying morphology, and neurofibrillary tangles (NFT) are major neuropathological characteristics in Alzheimer's disease (AD) affected brains.1) Twelve monoclonal antibodies (mcAb's) against cerebral amyloid were established. The antigens recognized were determined to be Abeta, C3, and C4. we characterized proteinchemically the antigen four mcAb's and two mcAb's recognized to be apoE and SP-40,40. The antigens recognized with Two mcAb's remained unidentified.2) Twenty two mcAb's against PHF were established. The reactive antigens were tau protein, neurofilaments, and ubiquitin. The antigens which the rest of mcAb's e recognized were unidentified.3) Using these mcAb's, immunohistochemical study showed that apoE was found in almost all amyloid depositions studied, and that there was a spatial relation between apoE overproducing astrocytes and plaques. NFT were stained with polyclonal apoE Ab, but not with our mcAb's. Competitive ELISA and Western blot analysis combined with thrombolytic digestion of apoE indicated that our four mcAb's recognized the epitopes within 22 kDa amino-terminal domain of apoE,and there were at least two distinct epitopes of the amino-terminal domain in amyloid depositions. SP-40,40 is present in various morphologies of Abeta depositions to a lessor degree and in astrocytes which are also located close to these depositions in brains affected by AD,and SDAT.These studies suggest that the mechanisms underlying the expression and processing of apoE,and SP-40,40 may be an essential issue in the pathogenesis of AD.
不同形态的脑淀粉样蛋白沉积和神经纤维缠结(NFT)是阿尔茨海默病(AD)影响脑的主要神经病理学特征。1)建立了12种抗脑淀粉样蛋白的单克隆抗体(McAb)。确定识别的抗原为Abeta、C3和C4。我们对抗原进行了蛋白化学表征,四种单克隆抗体和两种单克隆抗体被识别为apoE和SP-40,40。2)建立了22株抗PHF单克隆抗体。反应性抗原为tau蛋白、神经丝和泛素。3)免疫组化结果显示,apoE在所有的淀粉样沉积物中均有表达,且apoE过度表达的星形胶质细胞与斑块之间存在一定的空间关系。NFT用多克隆apoE Ab染色,但不用我们的mAb染色。竞争性ELISA和Western blot结合溶血栓酶切分析表明,4株单抗均识别apoE 22 kDa氨基端结构域内的表位,且在淀粉样蛋白沉积中至少存在2个不同的氨基端结构域表位。SP-40,40以较小程度存在于各种形态的Abeta沉积物中,并且存在于也位于受AD和SDAT影响的脑中的这些沉积物附近的星形胶质细胞中。这些研究表明,apoE和SP-40,40的表达和加工的潜在机制可能是AD发病机制中的重要问题。

项目成果

期刊论文数量(62)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takamaru Y et al: "SP-40,40 as an amyloid associated protein in Alzheimer's disease affected brains" (in preparation). (1995)
Takamaru Y 等人:“SP-40,40 作为阿尔茨海默病影响大脑中的淀粉样蛋白相关蛋白”(准备中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Aizawa Y,Fukatsu R,Takamaru Y,Tsuzuki K,Obara T,Fujii M,Kobayashi M,Takahata N,Gotoda T,Nagasawa S,Oguma K,Kunishita T and Tabira T: "Monoclonal antibodies against senile plaque amyloid in Alzheimer's disease" In Nagatsu T,Fisher A,Yoshida M (eds). Plenum
Aizawa Y、Fukatsu R、Takamaru Y、Tsuzuki K、Obara T、Fujii M、Kobayashi M、Takahata N、Gotoda T、Nagasawa S、Oguma K、Kunishita T 和 Tabira T:“针对阿尔茨海默病中老年斑淀粉样蛋白的单克隆抗体”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yuji Aizawa: "Monoclonal antibodies raised against native amyloid in Alzheimer's disease ーestablishment and characterizationー"
Yuji Aizawa:“针对阿尔茨海默病中的天然淀粉样蛋白产生的单克隆抗体 - 建立和表征 -”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yuji Takamaru: "Serum protein 40ー40 is involved in amyloid plaque formation in Alzheimer's desease."
Yuji Takamaru:“血清蛋白 40-40 参与阿尔茨海默病中淀粉样斑块的形成。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsuzuki K et al: "Potentially amyloidogenic fragment of 50 kDa and intracellular processing of amyloidprecursor protein in cell under leupept in" Brain Research. 659. 213-220 (1994)
Tsuzuki K 等人:“大脑研究中 leupept 下细胞中 50 kDa 的潜在淀粉样蛋白生成片段和淀粉样前体蛋白的细胞内加工”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUKATSU Ryo其他文献

FUKATSU Ryo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUKATSU Ryo', 18)}}的其他基金

Biochemical and molecular biological mechanisms underlying a to b cleavage and Ab biogenesis in Alzheimer disease
阿尔茨海默病中 a 至 b 裂解和 Ab 生物发生的生化和分子生物学机制
  • 批准号:
    12470197
  • 财政年份:
    2000
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The molecularbiological effect of AD disease genes on APP processing in cultured cells
AD疾病基因对培养细胞APP加工的分子生物学影响
  • 批准号:
    10470204
  • 财政年份:
    1998
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Novel Experimental Model in vitro for Amyloid beta Production and Molecular Biological Analysis of Amyloidogenesis
β淀粉样蛋白产生的新型体外实验模型和淀粉样蛋白生成的分子生物学分析
  • 批准号:
    07457211
  • 财政年份:
    1995
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular Biological Studies on Trafficking and Processing of Amyloid Precursor Protein
淀粉样前体蛋白运输和加工的分子生物学研究
  • 批准号:
    04454304
  • 财政年份:
    1992
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

PHASE 1 TRIAL FOR A THERAPEUTIC MONOCLONAL ANTIBODY FOR CHIKUNGUNYA VIRUS
基孔肯雅病毒治疗性单克隆抗体的第一阶段试验
  • 批准号:
    10892414
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
基本标题:预防临床前药理学和毒理学任务订单标题:使用人单克隆抗体 ATI-1013 进行尼古丁减少治疗
  • 批准号:
    10932479
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
用于治疗马尔堡病毒病的单克隆抗体混合物
  • 批准号:
    10761372
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
用单克隆抗体靶向心脏中的核酸外切酶以预防梗死后心力衰竭
  • 批准号:
    10711469
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
对抗铜绿假单胞菌的单克隆抗体
  • 批准号:
    10674274
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
Epitope-directed monoclonal antibody production for mosquito immune cells (for malaria)
针对蚊子免疫细胞(针对疟疾)的表位定向单克隆抗体生产
  • 批准号:
    10933280
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
On-cell screening of mouse hybridomas for improved monoclonal antibody discovery
小鼠杂交瘤的细胞筛选以改进单克隆抗体的发现
  • 批准号:
    10696698
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
Assessment of self-association of monoclonal antibody molecules by analysis of the protein layer detected at the proximity of a solid surface
通过分析在固体表面附近检测到的蛋白质层来评估单克隆抗体分子的自缔合
  • 批准号:
    10726173
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
STTR Phase I: Developing antifouling viral clearance membranes to enable efficient monoclonal antibody (mAb) processing
STTR 第一阶段:开发防污病毒清除膜以实现高效的单克隆抗体 (mAb) 处理
  • 批准号:
    2212947
  • 财政年份:
    2022
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Standard Grant
Development of transportable scFV monoclonal antibody into nucleus
可转运的scFV单克隆抗体进入细胞核的开发
  • 批准号:
    22K19387
  • 财政年份:
    2022
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了